Studies on the metabolic fate of M17055, a novel diuretic (6). Assessment for drug-drug interactions of M17055 in metabolism, distribution and excretion

Author： Nakajima H.   Nakanishi T.   Naba H.   Nakai K.   Matsumoto S.   Nagasawa K.   Ida K.   Ogihara T.   Ohzawa N.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.32, Iss.12, 2002-12, pp. : 1161-1172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of drug-drug interactions: concepts and approaches

By Weaver R. J.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 499-538

Informa Healthcare

Access to resources Recommend Favorite

Comparison of different approaches to predict metabolic drug–drug interactions

By Einolf H. J.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-06 ,pp. : 1257-1294

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions

By Miura M.   Ohkubo T.  

Xenobiotica, Vol. 34, Iss. 11-12, 2004-11 ,pp. : 1001-1011

Informa Healthcare

Access to resources Recommend Favorite

In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P450 enzyme identification, inhibition, and induction studies

By Li Yan   Zhou Diansong   Ferguson Stephen S.   Dorff Peter   Simpson Thomas R.   Grimm Scott W.  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 721-729

Informa Healthcare

Access to resources Recommend Favorite

Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug–drug interaction model rats

By Kanazu Takushi   Okamura Noboru   Yamaguchi Yoshitaka   Baba Takahiko   Koike Masahiro  

Xenobiotica, Vol. 35, Iss. 4, 2005-04 ,pp. : 305-317

Informa Healthcare

Access to resources Recommend Favorite